{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T11:23:31Z","timestamp":1784201011137,"version":"3.55.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,10,14]],"date-time":"2016-10-14T00:00:00Z","timestamp":1476403200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1007\/s00223-016-0198-3","type":"journal-article","created":{"date-parts":[[2016,10,14]],"date-time":"2016-10-14T04:02:41Z","timestamp":1476417761000},"page":"40-46","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Longitudinal Evaluation of Bone Mineral Density and Bone Metabolism Markers in Patients with Indolent Systemic Mastocytosis Without Osteoporosis"],"prefix":"10.1007","volume":"100","author":[{"given":"A.","family":"Artuso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Caimmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Tripi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Viapiana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bonifacio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Idolazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Gavioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Gatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Zanotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Rossini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,14]]},"reference":[{"key":"198_CR1","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/ajh.23459","volume":"88","author":"A Pardanani","year":"2013","unstructured":"Pardanani A (2013) Systemic mastocytosis in adults: 2013 update on diagnosis, risk stratification, and management. Am J Hematol 88:612\u2013624","journal-title":"Am J Hematol"},{"key":"198_CR2","first-page":"54","volume-title":"WHO classification of tumors of hematopoietic and lymphoid tissues","author":"HP Horny","year":"2008","unstructured":"Horny HP, Metcalfe DD, Bennett JM, Bain BJ, Akin C, Escribano L (2008) Mastocytosis. In: Swerdlow SH, Campo E, Harris NL (eds) WHO classification of tumors of hematopoietic and lymphoid tissues, 4th edn. IARC Press, Lyon, pp 54\u201363","edition":"4"},{"key":"198_CR3","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/BF01622200","volume":"4","author":"JA Kanis","year":"1994","unstructured":"Kanis JA (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO study Group. Osteoporos Int 4:368\u2013381","journal-title":"Osteoporos Int"},{"key":"198_CR4","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.iac.2014.01.011","volume":"34","author":"M Rossini","year":"2014","unstructured":"Rossini M, Zanotti R, Viapiana O, Tripi G, Orsolini G, Idolazzi L, Bonadonna P, Schena D, Escribano L, Adami S, Gatti D (2014) Bone involvement and osteoporosis in mastocytosis. Immunol Allergy Clin N Am 34:383\u2013396","journal-title":"Immunol Allergy Clin N Am"},{"key":"198_CR5","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1007\/s00198-016-3539-1","volume":"27","author":"M Rossini","year":"2016","unstructured":"Rossini M, Zanotti R, Orsolini G, Tripi G, Viapiana O, Idolazzi L, Zam\u00f2 A, Bonadonna P, Kunnathully V, Adami S, Gatti D (2016) Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis. Osteoporos Int 27:2411\u20132421","journal-title":"Osteoporos Int"},{"key":"198_CR6","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.bone.2008.08.106","volume":"43","author":"EM Lewiecki","year":"2008","unstructured":"Lewiecki EM, Gordon CM, Baim S, Leonard MB, Bishop NJ, Bianchi ML (2008) International society for clinical densitometry 2007 adult and pediatric official positions. Bone 43:1115\u20131121","journal-title":"Bone"},{"key":"198_CR7","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.bone.2011.07.004","volume":"49","author":"M Rossini","year":"2011","unstructured":"Rossini M, Zanotti R, Bonadonna P, Artuso A, Caruso B, Schena D, Vecchiato D, Bonifacio M, Viapiana O, Gatti D, Senna G, Riccio A, Passalacqua G, Pizzolo G, Adami S (2011) Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis. Bone 49:880\u2013885","journal-title":"Bone"},{"key":"198_CR8","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.jaci.2008.11.018","volume":"123","author":"P Bonadonna","year":"2009","unstructured":"Bonadonna P, Perbellini O, Passalacqua G, Caruso B, Colarossi S, Dal Fior D (2009) Clonal mast cell disorders in patients with systemic reactions to hymenoptera stings and raised serum tryptase. J Allergy Clin Immunol 123:680\u2013686","journal-title":"J Allergy Clin Immunol"},{"key":"198_CR9","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s001980170087","volume":"12","author":"Y Lu","year":"2001","unstructured":"Lu Y et al (2001) Standardization of bone mineral density at femoral neck, trochanter and ward\u2019s triangle. Osteoporos Int 12:438\u2013444","journal-title":"Osteoporos Int"},{"key":"198_CR10","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1359\/jbmr.1997.12.9.1463","volume":"12","author":"SL Hui","year":"1997","unstructured":"Hui SL et al (1997) Universal standardization of bone density measurements: a method with optimal properties for calibration among several instruments. J Bone Miner Res 12:1463\u20131470","journal-title":"J Bone Miner Res"},{"key":"198_CR11","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/jbmr.5650080915","volume":"8","author":"HK Genant","year":"1993","unstructured":"Genant HK, Wu CY, van Kuijk C, Nevitt MC (1993) Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8:1137\u20131148","journal-title":"J Bone Miner Res"},{"key":"198_CR12","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.jaci.2014.05.003","volume":"134","author":"E Veer van der","year":"2014","unstructured":"van der Veer E et al (2014) Predictors of new fragility fractures after diagnosis of indolent systemic mastocytosis. J Allergy Clin Immunol 134:1413\u20131421","journal-title":"J Allergy Clin Immunol"},{"key":"198_CR13","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.amjmed.2011.02.038","volume":"124","author":"M Laroche","year":"2011","unstructured":"Laroche M, Livideanu C, Paul C, Cantagrel A (2011) Interferon alpha and pamidronate in osteoporosis with fracture secondary to mastocytosis. Am J Med 124:776\u2013778","journal-title":"Am J Med"},{"issue":"11","key":"198_CR14","doi-asserted-by":"crossref","first-page":"1127.e1","DOI":"10.1016\/j.amjmed.2014.06.015","volume":"127","author":"M Rossini","year":"2014","unstructured":"Rossini M, Zanotti R, Viapiana O, Tripi G, Idolazzi L, Biondan M, Orsolini G, Bonadonna P, Adami S, Gatti D (2014) Zoledronic acid in osteoporosis secondary to mastocytosis. Am J Med 127(11):1127.e1\u20131127.e4","journal-title":"Am J Med"},{"key":"198_CR15","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1210\/jc.2011-2601","volume":"97","author":"MF Holick","year":"2012","unstructured":"Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM (2012) Guidelines for preventing and treating vitamin D deficiency and insufficiency revisited. J Clin Endocrinol Metab 97:1153\u20131158","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"198_CR16","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4081\/reumatismo.2011.129","volume":"63","author":"S Adami","year":"2011","unstructured":"Adami S, Romagnoli E, Carnevale V et al (2011) Guidelines on prevention and treatment of vitamin D deficiency. Italian society for osteoporosis, mineral metabolism and bone diseases (SIOMMMS). Reumatismo 63(3):129\u2013147","journal-title":"Reumatismo"},{"key":"198_CR17","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00223-013-9749-z","volume":"93","author":"M Rossini","year":"2013","unstructured":"Rossini M, Gatti D, Adami S (2013) Involvement of WNT\/\u03b2-catenin signaling in the treatment of osteoporosis. Calcif Tissue Int 93:121\u2013132","journal-title":"Calcif Tissue Int"},{"key":"198_CR18","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jaci.2013.12.007","volume":"133","author":"M Rossini","year":"2014","unstructured":"Rossini M, Adami S, Zanotti R, Viapiana O, Idolazzi L, Biondan M, Gatti D (2014) Serum levels of bone cytokines in indolent systemic mastocytosis associated with osteopenia or osteoporosis. J Allergy Clin Immunol 133:933\u2013935","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"198_CR19","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0889-8588(05)70298-7","volume":"14","author":"RT Jensen","year":"2000","unstructured":"Jensen RT (2000) Gastrointestinal abnormalities and involvement in systemic mastocytosis. Hematol Oncol Clin North Am 14(3):579\u2013623","journal-title":"Hematol Oncol Clin North Am"},{"issue":"2","key":"198_CR20","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000048182","volume":"127","author":"CY Li","year":"2002","unstructured":"Li CY, Baek JY (2002) Mastocytosis and fibrosis: role of cytokines. Int Arch Allergy Immunol 127(2):123\u2013126","journal-title":"Int Arch Allergy Immunol"},{"key":"198_CR21","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1002\/jbmr.5650051104","volume":"5","author":"L Graves 3rd","year":"1990","unstructured":"Graves L 3rd, Stechschulte DJ, Morris DC, Lukert BP (1990) Inhibition of mediator release in systemic mastocytosis is associated with reversal of bone changes. J Bone Miner Res 5:1113\u20131119","journal-title":"J Bone Miner Res"},{"key":"198_CR22","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2174\/187152806775269303","volume":"5","author":"L Escribano","year":"2006","unstructured":"Escribano L, Akin C, Castells M, Schwartz LB (2006) Current options in the treatment of mast cell mediator-related symptoms in mastocytosis. Inflamm Allergy Drug Targets 5:61\u201377","journal-title":"Inflamm Allergy Drug Targets"},{"issue":"16","key":"198_CR23","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1182\/blood-2013-01-453183","volume":"121","author":"A Pardanani","year":"2013","unstructured":"Pardanani A (2013) How I treat patients with indolent and smoldering mastocytosis (rare conditions but difficult to manage). Blood 121(16):3085\u20133094","journal-title":"Blood"},{"key":"198_CR24","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1359\/jbmr.1998.13.2.297","volume":"13","author":"PD Ross","year":"1998","unstructured":"Ross PD, Knowlton W (1998) Rapid bone loss is associated with increased levels of biochemical markers. J Bone Miner Res 13:297\u2013302","journal-title":"J Bone Miner Res"},{"key":"198_CR25","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1007\/s00198-013-2305-x","volume":"24","author":"S Seitz","year":"2013","unstructured":"Seitz S, Barvencik F, Koehne T et al (2013) Increased osteoblast and osteoclast indices in individuals with systemic mastocytosis. Osteoporos Int 24:2325\u20132334","journal-title":"Osteoporos Int"},{"key":"198_CR26","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.amjmed.2012.07.018","volume":"126","author":"N Guillaume","year":"2013","unstructured":"Guillaume N, Desoutter J, Chandesris O, Merlusca L, Henry I, Georgin-Lavialle S, Barete S, Hirsch I, Bouredji D, Royer B, Gruson B, Lok C, Sevestre H, Mentaverri R, Brazier M, Meynier J, Hermine O, Marolleau JP, Kamel S, Damaj G (2013) Bone complications of mastocytosis: a link between clinical and biological characteristics. Am J Med 126:75","journal-title":"Am J Med"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-016-0198-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00223-016-0198-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-016-0198-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T01:07:24Z","timestamp":1498352844000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00223-016-0198-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,14]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["198"],"URL":"https:\/\/doi.org\/10.1007\/s00223-016-0198-3","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,14]]}}}